Hakkında
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Eğitim ve öğretim
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Onkoloji
Kariyer ve atamalar
-
2017-09–2018-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
AE — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
Allianz Professional · 5,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 dk | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 dk | in_clinic | 360.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 11 · i10: 3
-
Validation of clinical scoring in Onkoloji
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · alıntılayan 130
-
Long-term follow-up of Onkoloji across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · alıntılayan 200
-
Validation of clinical scoring in Onkoloji
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · alıntılayan 118
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Dubai · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Dubai · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2018 yılından beri
- national college of family doctors — Member · 2018 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2018 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · ali.chamseddine@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
